Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00046930
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2002-10-03
Brief Title:
Daunorubicin Cytarabine - Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| adult acute myeloid leukemia with t821q22q22 | View |
| adult acute monocytic leukemia M5b | View |
| adult acute erythroid leukemia M6 | View |
| adult acute megakaryoblastic leukemia M7 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute monoblastic leukemia M5a | View |
| refractory anemia with excess blasts in transformation | View |
| refractory anemia with excess blasts | View |
| secondary acute myeloid leukemia | View |
| untreated adult acute myeloid leukemia | View |
| de novo myelodysplastic syndromes | View |
| adult acute minimally differentiated myeloid leukemia M0 | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |